Chan Andrew C.
SEC insider (Form 3/4/5 filer). CIK 0002131504. Director at Corvus Pharmaceuticals, Inc. (CRVS). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 23, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Chan Andrew C. has filed insider reports for
- Corvus Pharmaceuticals, Inc. (CRVS): Director
Chan Andrew C.
CIK: 0002131504
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRVS
Corvus Pharmaceuticals, Inc.
Director